InnoCare Pharma’s Post

View organization page for InnoCare Pharma, graphic

2,615 followers

An in-depth interview with our Co-founder & CEO Dr. Jasmine Cui from PharmaBoardroom. The interview discussed tapping into the burgeoning Chinese innovation landscape, building a stable yet dynamic company culture, differentited pipeline, and global strategy, etc. Innovation knows no boundaries, and we are dedicated to collaborating with global partners to bring our transformative therapies to patients worldwide. Well worth a read: https://lnkd.in/g6U4kXk7

View organization page for PharmaBoardroom, graphic

11,888 followers

Off the back of strong financials for the first half of 2024 (an 11.2% increase in revenue and a 19.3% rise in gross profit compared to the same period in 2023), we are delighted to share our recent interview with InnoCare Pharma CEO Jasmine Cui. After a glittering career in corporate America, in 2011 Cui returned to China and in 2015 launched her own biotech, Innocare. The commercial-stage firm, which focuses on oncology and autoimmune disease R&D, has its BTK inhibitor approved in China and is seeking further approvals in the US and beyond. In conversation Cui discusses tapping into the burgeoning Chinese innovation landscape, building a stable yet dynamic company culture, and the next steps in Innocare's internationalisation journey. Read the full interview at: https://lnkd.in/g6U4kXk7

To view or add a comment, sign in

Explore topics